Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations
Author:
Affiliation:
1. Department of Pharmacy; King Hussein Cancer Center; Amman Jordan
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.803/fullpdf
Reference25 articles.
1. 2012
2. Docetaxel for treatment of solid tumors: a systematic review of clinical data;Montero;Lancet Oncol,2005
3. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients;Renner;Cochrane Database Syst Rev,2012
4. Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors;Pfeil;BMC Cancer.,2014
5. Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients;Poirier;Ann Pharmacother,2014
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Febrile neutropenia incidence and the variable toxicity profile between brand and generic docetaxel in the adjuvant treatment of breast cancer with docetaxel and cyclophosphamide regimen;einstein (São Paulo);2023
2. Changing manufacturer to address neutropenia induced by non-clozapine second-generation antipsychotics;Journal of the American Pharmacists Association;2022-07
3. Differences between the quality aspects of various generic and branded docetaxel formulations;Current Medical Research and Opinion;2021-06-07
4. Comparing incidences of infusion site reactions between brand‐name and generic vinorelbine in patients with non‐small cell lung cancer;British Journal of Clinical Pharmacology;2020-08-31
5. Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study;Journal of Translational Medicine;2020-06-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3